12:00 AM
Mar 13, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

Cytoporin synthetic lytic peptides regulatory update

HXBM received Japanese Patent No. 2,962,555 and Canadian Patent No. 1,340,716 covering the...

Read the full 42 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >